India, Feb. 12 -- On 12th February 1809 in Shrewsbury, England, a boy was born who would later be responsible for how humans ...

Life’s story may stretch further back than scientists once thought. Some genes found in nearly every organism today were already duplicated before all life shared a common ancestor. By tracking these ...

CBSE Class 12 Biology last 10 days study plan for board exam 2026 with detailed day-wise revision strategy, daily timetable, high-weightage chapters, and exam-focused tips.

Dark-eyed junco songbirds have been serenading the University of California, Los Angeles campus for decades as they forage for food. The species from the sparrow family is not usually found in cities.

With the Class 12 board examinations approaching, the CBSE Biology sample paper offers students a clear guide to the exam pattern, marking scheme and key topics ahead of the March 27 test. The Central ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that ...

Human evolution’s biggest mystery, which emerged 15 years ago from a 60,000-year-old pinkie finger bone, finally started to unravel in 2025. Analysis of DNA extracted from the fossil electrified the ...

The trade-off between quality and quantity is a fundamental economic dilemma. Now, a team of British, American, and Japanese researchers describes how it applies to biology, as well. They have ...

Biology exam for CBSE Class 12 is scheduled for March 27, 2026, with 33 compulsory questions The question paper has five sections with marks ranging from 1 to 5 for different question types ...

Why did humans evolve the eyes we have today? While scientists can't go back in time to study the environmental pressures that shaped the evolution of the diverse vision systems that exist in nature, ...

KALA BIO, Inc. (NASDAQ: KALA) shares jumped 22.16% to $1.13 in after-hours trading on Wednesday. Check out the current price of KALA stock here. Securities and Exchange Commission filings indicate ...

Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...